2021 Volume 34 Issue 2 Pages 362-366
Objective : To evaluate the effectiveness and safety using contact laser vaporization of the prostate for symptomatic benign prostatic hyperplasia. Materials and Methods : From June 2019 to August 2020, 46 patients with benign prostatic hyperplasia underwent contact laser vaporization of the prostate at our institution. Patients were assessed preoperatively and at 1, 3 and 6 months postoperatively involving their IPSS, QOL score, maximum flow rate, and post-void residual urine volume. Results : The mean age was 70.3±6.4 years old. The preoperative mean prostate volume was 90.5±32.7 mL. The operative time was 102.5±21.4 minutes, and total applied laser energy was 466.4±110.6 kJ. The procedure was completed successfully in all patients without intraoperative complications. None of the patients required blood transfusion postoperatively. All of the parameters were improved and comparable with those in the Japanese clinical trial after surgery. Conclusions : contact laser vaporization of the prostate was demonstrated highly therapeutic potential and safety procedure for benign prostatic hyperplasia patients.
